can i use hsa for semaglutide for weight loss vs. Tirzepatide: Which GLP-1 Is Right You? Choosing Oral vs. Injectable Semaglutide

Animal studies suggest that GIPR signaling may help reduce nausea caused by GLP-1RA [32]

IMPORTANT: As of September 2024, it is alleged, and not yet proven, that the drugs listed above may cause serious health problems like gastroparesis, pancreatitis, pancreatic cancer, and others

Some samples contained heavy metals including lead and cadmium at levels exceeding USP limits (FDA Safety Communication, 2025)

RetatrutideMounjaro (Tirzepatide)Wegovy (Semaglutide) Mechanism Triple (GLP-1 + GIP + Glucagon)Dual (GLP-1 + GIP)Single (GLP-1) Best weight loss in trials 30.3%22.5%20.7% Trial duration 104 weeks72 weeks72 weeks UK approval Not yetYes (Mounjaro)Yes (Wegovy) Injection frequency Once weeklyOnce weeklyOnce weekly One important caveat: the 30.3% figure comes from a 104-week trial, while the Mounjaro and Wegovy results are from 72-week trials

Found offers: Found-affiliated clinicians who personalize your weight care treatment plan to work with your biology